why choose us

First received: August 12, 2022

Clinical Trial: Using Fostamatinib to Treat Post-Hematopoietic Stem Cell Transplant Immune-mediated Cytopenias

Study Status: Completed

Recruit Status: RECRUITING

Condition: Immune Mediated Anemia

Study Type: INTERVENTIONAL


Official Title: A Phase II Study Using Fostamatinib to Treat Post-Hematopoietic Stem Cell Transplant Immune-Mediated Cytopenias

Brief Summary: Background:People who have a blood stem cell transplant can sometimes develop cytopenia.This means that their levels of one or more types of blood cell, such as the red cells or platelets, are lower than they should be.This can occur because a person s immune system might attack these cells after a stem cell transplant.Cytopenia can lead to anemia, severe bleeding, infections, and other problems.Treatments are needed to help keep blood cell levels stable after blood stem cell transplant.Objective:To test a study…

Read more